Literature DB >> 21343773

Risk of venous thromboembolism during the postpartum period: a systematic review.

Emily Jackson1, Kathryn M Curtis, Mary E Gaffield.   

Abstract

OBJECTIVE: To determine, from the literature, the risk of venous thromboembolism during the postpartum period. DATA SOURCES: We searched PubMed and Cochrane Library databases for all articles (in all languages) published in peer-reviewed journals from database inception through May 2010 for evidence related to incidence of venous thromboembolism in postpartum women. METHODS OF STUDY SELECTION: We included studies reporting relative risk, incidence rate, or cumulative incidence of venous thromboembolism in postpartum women. TABULATION, INTEGRATION, AND
RESULTS: We included 15 articles reporting findings from 13 studies. Two studies directly comparing venous thromboembolism during the first 6 weeks postpartum to nonpregnant, nonpostpartum women reported relative effect measures of 21.5 (rate ratio; 95% confidence interval [CI] unable to be calculated) and 84 (odds ratio; 95% CI 31.7-222.6), respectively. A third study reported relative effect measures for deep venous thrombosis (15.2, 95% CI 13.2-17.6; standardized incidence ratio) and pulmonary embolism (9.2, 95% CI 6.5-12.7) separately. Three studies reported incidence rates of venous thromboembolism during the postpartum period (range 25-99 per 10,000 woman-years). We compared these incidence rates to baseline rates among nonpregnant, nonpostpartum women reported in the literature to generate rate ratios; these rate ratios ranged from 2.5 to 21.5. Nine studies reported cumulative incidence proportions of postpartum venous thromboembolism, ranging from 0.14 to 3.24 per 1,000 deliveries at 6 weeks postpartum. Incidence of venous thromboembolism was highest immediately after delivery (standardized incidence ratio for deep venous thrombosis 115.1 [95% CI 96.4-137.0], and for pulmonary embolism 80.7 [95% CI 53.9-117.9]); between 4 and 6 weeks postpartum, risk declined but was still approximately five-times to seven-times that of nonpregnant, nonpostpartum women.
CONCLUSION: During the first 6 weeks postpartum, women's risk of venous thromboembolism increased 21.5-fold to 84-fold from baseline in nonpregnant, nonpostpartum women in studies that included an internal reference group. Although incidence of venous thromboembolism declined quickly after delivery, when this risk returns to baseline is not clear from current data.

Entities:  

Mesh:

Year:  2011        PMID: 21343773     DOI: 10.1097/AOG.0b013e31820ce2db

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

Review 1.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

2.  Venous thromboembolism and stroke in pregnancy.

Authors:  Kelley McLean; Mary Cushman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009.

Authors:  Nafisa Ghaji; Sheree L Boulet; Naomi Tepper; William C Hooper
Journal:  Am J Obstet Gynecol       Date:  2013-06-26       Impact factor: 8.661

4.  Health Care Provider Attitudes Toward Safety of Selected Hormonal Contraceptives in Breastfeeding Women.

Authors:  Allison Mayhew; Yokabed Ermias; Lauren B Zapata; H Pamela Pagano; Naomi K Tepper
Journal:  Matern Child Health J       Date:  2019-08

5.  Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort.

Authors:  Rie Adser Virkus; Ellen Løkkegaard; Øjvind Lidegaard; Jens Langhoff-Roos; Anne Kristine Nielsen; Kenneth J Rothman; Thomas Bergholt
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

6.  Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.

Authors:  Loïc Sentilhes; Valérie Daniel; Astrid Darsonval; Philippe Deruelle; Delphine Vardon; Franck Perrotin; Camille Le Ray; Marie-Victoire Senat; Norbert Winer; Françoise Maillard; Catherine Deneux-Tharaux
Journal:  BMC Pregnancy Childbirth       Date:  2015-06-14       Impact factor: 3.007

Review 7.  Optimizing maternal and neonatal outcomes with postpartum contraception: impact on breastfeeding and birth spacing.

Authors:  Aparna Sridhar; Jennifer Salcedo
Journal:  Matern Health Neonatol Perinatol       Date:  2017-01-13

8.  Case-crossover study to examine the change in postpartum risk of pulmonary embolism over time.

Authors:  Grégoire Ficheur; Alexandre Caron; Jean-Baptiste Beuscart; Laurie Ferret; Yu-Jin Jung; Charles Garabedian; Régis Beuscart; Emmanuel Chazard
Journal:  BMC Pregnancy Childbirth       Date:  2017-04-14       Impact factor: 3.007

9.  Systemic Thrombolysis for Treatment of Postpartum Saddle Embolism Complicated by Postpartum Hemorrhage: A Case Report and Brief Literature Review.

Authors:  Kathy Mostajeran; Hillary Boswell; Ziad Haidar
Journal:  Case Rep Obstet Gynecol       Date:  2021-06-29

10.  Cerebral Venous Sinus Thrombosis in Women: Subgroup Analysis of the VENOST Study.

Authors:  Derya Uluduz; Sevki Sahin; Taskin Duman; Serefnur Ozturk; Vildan Yayla; Nazire Afsar; Nevzat Uzuner; Ipek Midi; Nilgun Cinar; Mehmet Ali Sungur; Fusun Mayda Domac; Birsen Ince; Baki Goksan; Cemile Handan Misirli; Mustafa Bakar; Hasan Huseyin Kozak; Sena Colakoglu; Ali Yavuz Karahan; Eylem Ozaydin Goksu; Fatih Ozdag; Mehmet Guney Senol; Vedat Ali Yurekli; Ufuk Aluclu; Serkan Demir; Hayriye Kucukoglu; Serdar Oruc; Nilufer Yesilot; Ozge Yimaz Kusbeci; Bijen Nazliel; Firdevs Ezgi Ucan Tokuc; Hesna Bektas; Fatma Nida Tascilar; Emrah Aytac; Mustafa Gokce; Hale Zeynep Batur Caglayan; Ahmet Tufekci; Gulnur Uzuner; Dilek Necioglu Orken; Osman Ozgur Yalin; Uygar Utku; Arda Yilmaz; Hamit Genc; Murat Cabalar; Aysel Milanlioglu; Hakan Ekmekci; Burcu Zeydan; Sevim Baybas; Yuksel Kablan; Basak Karakurum Goksel; Mustafa Acikgoz; Hatice Kurucu; Seden Demirci; Taskin Gunes
Journal:  Stroke Res Treat       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.